secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001437749-25-016500
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart appoints Jeroen Grasman as CFO, replaces Phillip Lee
-----------------------------------------------------------

- CFO Phillip Lee resigns effective upon appointment of successor; no disagreement; remains as non-executive employee through June 1, 2025.
- Jeroen Grasman appointed CFO effective May 19, 2025; previously CFO at AltruBio, VP Finance at PACT Pharma and Genentech.
- Grasman receives base salary $435K, target bonus 40%, option for 1M shares vesting over 48 months, RSU for 350K shares.
- Lee forfeits unvested equity upon termination; no termination benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774925016500/0001437749-25-016500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774925016500/vxrt20250513_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-016500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer